Vedolizumab Achieves Corticosteroid-Free Clinical Response and Remission in Inflammatory Bowel Disease: A Real World Meta-Analysis

被引:0
|
作者
Shaw, Caroline [1 ]
Brown, Rebecca [1 ]
Wang, Song [2 ]
Adsul, Shashi [3 ]
Agboton, Christian [3 ]
Kamble, Pravin [2 ]
机构
[1] PHMR, London, England
[2] Takeda, Cambridge, MA USA
[3] Takeda, Zurich, Switzerland
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S0688
引用
收藏
页码:S345 / S345
页数:1
相关论文
共 50 条
  • [41] Systematic review and meta-analysis: Safety of vedolizumab during pregnancy in patients with inflammatory bowel disease
    Bell, Conor
    Tandon, Parul
    Lentz, Eric
    Marshall, John K.
    Narula, Neeraj
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (10) : 2640 - 2648
  • [42] Safety and Efficacy of Vedolizumab in Elderly Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Dahiya, Dushyant S.
    Chandan, Saurabh
    Bapaye, Jay
    Mohan, Babu P.
    Ramai, Daryl
    Kassab, Lena L.
    Chandan, Ojasvini C.
    Dulai, Parambir S.
    Kochhar, Gursimran S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S627 - S627
  • [43] Association of inflammatory bowel disease with the risk of Parkinson's disease: A meta-analysis of real-world evidence
    Hussain, Salman
    Najmi, Abul Kalam
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 151 - 151
  • [44] Corticosteroid-Free Remission vs Overall Remission in Clinical Trials of Moderate-Severe Ulcerative Colitis and Crohn's Disease
    George, John
    Singh, Siddharth
    Dulai, Parambir S.
    Ma, Christopher
    Tran Minh Nguyen
    Feagan, Brian G.
    Sandborn, William J.
    Jairath, Vipul
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (04) : 515 - 523
  • [45] Clinical remission in paired phase two and three studies in inflammatory bowel disease: a systematic review with meta-analysis
    Tandon, Parul
    Natt, Navneet
    Malhi, Gurpreet
    Wong, Emily C. L.
    Matthews, Priscilla
    Reinisch, Walter
    Narula, Neeraj
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 35 (03) : 231 - 240
  • [46] Maintenance of clinical remission with biologics and small molecules in inflammatory bowel disease according to trial design: Meta-analysis
    Barberio, Brigida
    Gracie, David J.
    Black, Christopher J.
    Ford, Alexander C.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (01) : 7 - 14
  • [47] A Systematic Review and Meta-Analysis of 6-Thioguanine Nucleotide Levels and Clinical Remission in Inflammatory Bowel Disease
    Estevinho, Maria Manuela
    Afonso, Joana
    Rosa, Isadora
    Lago, Paula
    Trindade, Eunice
    Correia, Luis
    Dias, Claudia Camila
    Magro, Fernando
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (11): : 1381 - 1392
  • [48] Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab
    Jessica R. Allegretti
    Edward L. Barnes
    Betsey Stevens
    Margaret Storm
    Ashwin Ananthakrishnan
    Vijay Yajnik
    Joshua Korzenik
    Digestive Diseases and Sciences, 2017, 62 : 1590 - 1596
  • [49] Prebiotics for Induction and Maintenance of Remission in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
    Limketkai, Berkeley N.
    Godoy-Brewer, Gala
    Shah, Neha D.
    Maas, Laura
    White, Jacob
    Parian, Alyssa M.
    Mullin, Gerard E.
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [50] Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab
    Allegretti, Jessica R.
    Barnes, Edward L.
    Stevens, Betsey
    Storm, Margaret
    Ananthakrishnan, Ashwin
    Yajnik, Vijay
    Korzenik, Joshua
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (06) : 1590 - 1596